Axsome Therapeutics Reports Q3 2026 Financial Results
News related to:Axsome Therapeutics · 3 min read
NEW YORK, Oct. 07, 2026 /CourierPR/ -- Axsome Therapeutics, a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, announced today that it will report its financial results for the third quarter of 2026 on Monday, November 2, 2026, before the opening of the U.S. financial markets. The company will host a conference call at 8:00 a.m. Eastern Time to discuss these results and provide a business update.
To participate in the live conference call, interested parties are invited to dial (877) 405-1239 (toll-free domestic) or (toll-free domestic) or +1 (201) 389-0851 (international). A live webcast of the conference call will be available on the Company’s website for approximately 30 days following the live event.
Axsome Therapeutics, a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) conditions, will report its financial results for the third quarter of 2026 on Monday, November 2, 2026, before the opening of the U.S. financial markets. The company will host a conference call at 8:00 a.m. Eastern Time to discuss these results and provide a business update.
To participate in the live conference call, interested parties are invited to dial (877) 405-1239 (toll-free domestic) or +1 (201) 389-0851 (international). A live webcast of the conference call will be available on the Company’s website for approximately 30 days following the live event.
The company will report its financial results for the third quarter of 2026 on Monday, November 2, 2026, before the opening of the U.S. financial markets. It will host a conference call at 8:00 a.m. Eastern Time to discuss these results and provide a business update. Interested parties are invited to dial (877) 405-1239 (toll-free domestic) or +1 (201) 389-0851 (international) to participate in the live conference call. A live webcast of the conference call will be available on the Company’s website for approximately 30 days following the live event.
Axsome Therapeutics, a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) conditions, will report its financial results for the third quarter of 2026 on Monday, November 2, 2026, before the opening of the U.S. financial markets. The company will host a conference call at 8:00 a.m. Eastern Time to discuss these results and provide a business update. Interested parties are invited to dial (877) 405-1239 (toll-free domestic) or +1 (201) 389-0851 (international) to participate in the live conference call. A live webcast of the conference call will be available on the Company’s website for approximately 30 days following the live event.
Axsome Therapeutics will report its financial results for the third quarter of 2026 on Monday, November 2, 2026, before the opening of the U.S. financial markets. The company will host a conference call at 8:00 a.m. Eastern Time to discuss these results and provide a business update. Interested parties are invited to dial (877) 405-1239 (toll-free domestic) or +1 (201) 389-0851 (international) to participate in the live conference call. A live webcast of the conference call will be available on the Company’s website for approximately 30 days following the live event.
Axsome Therapeutics, a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) conditions, will report its financial results for the third quarter of 2026 on Monday, November 2, 2026, before the opening of the U.S. financial markets. The company will host a conference call at 8:00 a.m. Eastern Time to discuss these results and provide a business update. Interested parties are invited to dial (877) 405-1239 (toll-free domestic) or +1 (201) 389-0851 (international) to participate in the live conference call. A live webcast of the conference call will be available on the Company’s website for approximately 30 days following the live event.
Axsome Therapeutics will report its financial results for the third quarter of 2026 on Monday, November 2, 2026, before the opening of the U.S. financial markets. The company will host a conference call at 8:00 a.m. Eastern Time to discuss these results and provide a business update. Interested parties are invited to dial (877) 405-1239 (toll-free domestic) or +1 (201) 389-0851 (international) to participate in the live conference call. A live webcast of the conference call will be available on the Company’s website for approximately 30 days following the live event.